Scientists from The University of Texas at Arlington and the University of North Texas Health Science Center are building a prototype for an implantable in-line shunt flow monitoring system that would ...
The control of tumour growth by restricting angiogenesis has attracted tremendous attention in recent years. The initial work using anti-angiogenic drugs alone was promising but did not translate into ...
BOSTON, MA—One-year outcomes from an early feasibility study (EFS) show durable improvements in symptoms and quality of life in symptomatic heart failure (HF) patients treated with a novel coronary ...
MedPage Today on MSN
Interatrial Shunt to Go Before FDA Panel for Heart Failure Indication
Ventura's permanent interatrial shunt was designed to shunt blood from the left to right atrium to improve symptoms in patients with advanced chronic heart failure. The hourglass-shaped, nitinol-frame ...
Alcyone Lifesciences Receives FDA Clearance for the Alivio System for the Treatment of Hydrocephalus
LOWELL, Mass., Nov. 15, 2017 /PRNewswire/ -- Alcyone Lifesciences, Inc., announced that the U.S. Food and Drug Administration (FDA) cleared the Alivio Ventricular Catheter & Flusher System (Alivio ...
A ventriculoperitoneal (VP) shunt is a medical device that relieves pressure on the brain caused by the accumulation of fluid. Ventriculoperitoneal (VP) shunts are primarily used to treat a condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback